Clinical Trial Update: Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial in Mali assessing the tolerable dose of primaquine in G6PD-deficient individuals without malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED